- Home
- ITUB vs ZTS Comparison
ITUB vs ZTS Comparison
Compare ITUB & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITUB
- ZTS
- Stock Information
- Founded
- ITUB 1924
- ZTS 1952
- Country
- ITUB Brazil
- ZTS United States
- Employees
- ITUB N/A
- ZTS N/A
- Industry
- ITUB Major Banks
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- ITUB Finance
- ZTS Health Care
- Exchange
- ITUB Nasdaq
- ZTS Nasdaq
- Market Cap
- ITUB 71.1B
- ZTS 73.2B
- IPO Year
- ITUB N/A
- ZTS 2013
- Fundamental
- Price
- ITUB $6.31
- ZTS $155.02
- Analyst Decision
- ITUB Buy
- ZTS Buy
- Analyst Count
- ITUB 3
- ZTS 8
- Target Price
- ITUB $6.27
- ZTS $211.50
- AVG Volume (30 Days)
- ITUB 26.5M
- ZTS 2.9M
- Earning Date
- ITUB 08-05-2025
- ZTS 08-05-2025
- Dividend Yield
- ITUB 6.44%
- ZTS 1.29%
- EPS Growth
- ITUB 25.90
- ZTS 7.32
- EPS
- ITUB 0.67
- ZTS 5.57
- Revenue
- ITUB $24,044,475,384.00
- ZTS $9,286,000,000.00
- Revenue This Year
- ITUB $36.38
- ZTS $3.54
- Revenue Next Year
- ITUB $7.66
- ZTS $6.11
- P/E Ratio
- ITUB $9.41
- ZTS $27.82
- Revenue Growth
- ITUB 6.06
- ZTS 6.32
- 52 Week Low
- ITUB $4.42
- ZTS $139.70
- 52 Week High
- ITUB $6.95
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- ITUB 35.87
- ZTS 39.36
- Support Level
- ITUB $6.71
- ZTS $156.26
- Resistance Level
- ITUB $6.95
- ZTS $161.77
- Average True Range (ATR)
- ITUB 0.13
- ZTS 3.29
- MACD
- ITUB -0.05
- ZTS -0.13
- Stochastic Oscillator
- ITUB 8.49
- ZTS 25.11
About ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.